ARTICLE | Company News
CeNeS, Cangene deal
February 12, 2001 8:00 AM UTC
CEN will develop for CNJ a sustained release formulation of an undisclosed biopharmaceutical using its Depocore technology. CEN will receive an initial fee to develop and test the new formulation, plu...